Baclofen

CAS 1134-47-0 12 current records 4 historicalSmall Molecule

Who holds supplier records for Baclofen? 12 organisations hold a current record for Baclofen: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), South Africa (1), Germany (1), France (1) and 2 other countries (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Baclofen: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/baclofen

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Baclofen expires 29 Sept 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Baclofen. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Baclofen sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Baclofen, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
MANKIND PHARMA LIMITED New DelhiIN
CEP 2025-372 - Rev 00
Baclofen, Micronised and non-micronised
Sept 2026—
VIYASH SCIENTIFIC LIMITED HyderabadIN
CEP 2024-145 - Rev 02
Baclofen
Jul 2026—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2018-280 - Rev 03
Baclofen
Jan 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2006-229 - Rev 03
Baclofen
Oct 2025—
PCAS EcullyFR
CEP 2003-247 - Rev 02
Baclofen
Sept 2025—
MEDILUX LABORATORIES PRIVATE LIMITED PithampurIN
CEP 2017-133 - Rev 02
Baclofen
Jul 2025Inspected Nov 2025
Germany
PIRAMAL PHARMA LIMITED Digwal VillageIN
CEP 2016-313 - Rev 01
Baclofen
May 2025Inspected Jun 2025
Netherlands
BIOINDUSTRIA L.I.M. S.P.A. Novi LigureIT
CEP 2011-360 - Rev 02
Baclofen
Mar 2025Inspected Apr 2025
Italy
ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdańskiPL
CEP 2010-316 - Rev 07
Baclofen, Standard, milled, micronised
Feb 2025Inspected Jul 2026
Poland
EXCELLA GMBH & CO. KG FeuchtDE
CEP 2007-238 - Rev 05
Baclofen, Milled, sieved
Jan 2025Inspected Apr 2026
Germany

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Baclofen are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
    Inactive DMF 12438 · filed Mar 1997
  • RESOLUTION CHEMICALS LTD
    Inactive DMF 9837, 7368 · filed Aug 1992
  • Italy · Inactive DMF 7817 · filed Dec 1988
  • ICFI SPA
    Inactive DMF 7499 · filed May 1988

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (69 listed products contain Baclofen). The latest listed patent expires 29 Sept 2041. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Baclofen is a centrally acting skeletal muscle relaxant and an antispastic agent, primarily used for the treatment of spasticity. It functions as a GABA_B receptor agonist, which helps reduce muscle spasms and is commonly used in cases of multiple sclerosis, spinal cord injuries, or diseases.

Chemical identity

IUPAC name
4-amino-3-(4-chlorophenyl)butanoic acid
Canonical SMILES
C1=CC(=CC=C1C(CC(=O)O)CN)Cl
InChIKey
KPYSYYIEGFHWSV-UHFFFAOYSA-N
Synonyms
Lioresal API, (rs)-baclofen, ba-34,647, ba-34647, fleqsuvy, gablofen, kemstro, lioresal, lyvispah, nsc-755906, ozobax

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
gamma-Aminobutyric Acid-ergic Agonist
Mechanism of action
GABA A Agonists; GABA B Agonists

Therapeutic areas

NeurologyMuscular Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Baclofen?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Baclofen: Fine Chemicals Corporation (PTY) Ltd. (South Africa), COHANCE LIFESCIENCES LTD (India), EXCELLA GMBH AND CO KG (Germany), Mankind Pharma Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), MEDILUX LABORATORIES PVT LTD (India), PCAS (France) and Piramal Pharma Limited (India), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Baclofen Drug Master Files are active?

Fine Chemicals Corporation (PTY) Ltd. (DMF 6421, 35224), COHANCE LIFESCIENCES LTD (DMF 33302), EXCELLA GMBH AND CO KG (DMF 7311), Mankind Pharma Limited (DMF 37011), MATRIX PHARMACORP PRIVATE LTD (DMF 18220), MEDILUX LABORATORIES PVT LTD (DMF 35654), PCAS (DMF 7077) and Piramal Pharma Limited (DMF 28455) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Baclofen records mean?

4 organisations have only inactive Type II DMFs for Baclofen. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Baclofen have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Baclofen on the EDQM register, including MANKIND PHARMA LIMITED New Delhi (IN), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), COHANCE LIFESCIENCES LIMITED Mumbai (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), PCAS Ecully (FR) and MEDILUX LABORATORIES PRIVATE LIMITED Pithampur (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Baclofen?

Yes. The latest patent listed for an approved US product containing Baclofen expires 29 Sept 2041, across 69 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Baclofen supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Baclofen?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.